{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"26"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"27"}],"units":"Participants"}],"description":"The number of response rates participants with SD, MR, PR, VGPR, or CR","groups":[{"description":"All patients received oral panobinostat, lenalidomide and dexamethasone as per protocol","id":"OG000","title":"Panobinostat, Lenalidomide and Dexamethasone"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"up to 4 years","title":"Disease Control Rate","type":"SECONDARY","unitOfMeasure":"Participants"}